1.Sinomenine ester derivative inhibits glioblastoma by inducing mitochondria-dependent apoptosis and autophagy by PI3K/AKT/mTOR and AMPK/mTOR pathway.
Xiangjin ZHENG ; Wan LI ; Huanli XU ; Jinyi LIU ; Liwen REN ; Yihui YANG ; Sha LI ; Jinhua WANG ; Tengfei JI ; Guanhua DU
Acta Pharmaceutica Sinica B 2021;11(11):3465-3480
		                        		
		                        			
		                        			Glioblastoma multiforme (GBM) in the central nervous system is the most lethal advanced glioma and currently there is no effective treatment for it. Studies of sinomenine, an alkaloid from the Chinese medicinal plant,
		                        		
		                        		
		                        		
		                        	
2.The biology, function, and applications of exosomes in cancer.
Jinyi LIU ; Liwen REN ; Sha LI ; Wan LI ; Xiangjin ZHENG ; Yihui YANG ; Weiqi FU ; Jie YI ; Jinhua WANG ; Guanhua DU
Acta Pharmaceutica Sinica B 2021;11(9):2783-2797
		                        		
		                        			
		                        			Exosomes are cell-derived nanovesicles with diameters from 30 to 150 nm, released upon fusion of multivesicular bodies with the cell surface. They can transport nucleic acids, proteins, and lipids for intercellular communication and activate signaling pathways in target cells. In cancers, exosomes may participate in growth and metastasis of tumors by regulating the immune response, blocking the epithelial-mesenchymal transition, and promoting angiogenesis. They are also involved in the development of resistance to chemotherapeutic drugs. Exosomes in liquid biopsies can be used as non-invasive biomarkers for early detection and diagnosis of cancers. Because of their amphipathic structure, exosomes are natural drug delivery vehicles for cancer therapy.
		                        		
		                        		
		                        		
		                        	
3.Common factor analysis of teaching effect evaluation for integrated curriculum of basic medicine
Lu ZHAO ; Youfei GUAN ; Weiwei LIU ; Tingting MENG ; Xiangjin KONG
Chinese Journal of Medical Education Research 2021;20(4):438-441
		                        		
		                        			
		                        			Objective:To extract the common factors for evaluating the teaching effect of the integrated curriculum of basic medicine in China, and to analyze and explain the practical significance of these common factors.Methods:A questionnaire survey was conducted among undergraduates of 15 medical colleges in China to evaluate the teaching effect of integrated curriculum of basic medicine, and exploratory factor analysis was conducted for screening and classification. SPSS 22.0 was used to conduct factor analysis.Results:The four major common factors evaluating the teaching effect of integrated curriculum were the effectiveness of teaching process, the rationality of teaching organization, the education of teaching content, and the innovation of teaching methods.Conclusion:The integrated curriculum reform of basic medicine should pay great attention to the simultaneous development of basic theory learning and practical ability training, the effective connection between theoretical teaching and experimental teaching, the educational role in comprehensive quality cultivation of students, and the flexible application of various teaching means and methods.
		                        		
		                        		
		                        		
		                        	
4.3--Acetyl-11-keto- -boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma.
Wan LI ; Liwen REN ; Xiangjin ZHENG ; Jinyi LIU ; Jinhua WANG ; Tengfei JI ; Guanhua DU
Acta Pharmaceutica Sinica B 2020;10(2):301-312
		                        		
		                        			
		                        			Glioblastoma is the most common and aggressive primary tumor in the central nervous system, accounting for 12%-15% of all brain tumors. 3--Acetyl-11-keto--boswellic acid (AKBA), one of the most active ingredients of gum resin from Birdw., was reported to inhibit the growth of glioblastoma cells and subcutaneous glioblastoma. However, whether AKBA has antitumor effects on orthotopic glioblastoma and the underlying mechanisms are still unclear. An orthotopic mouse model was used to evaluate the anti-glioblastoma effects of AKBA. The effects of AKBA on tumor growth were evaluated using MRI. The effects on the alteration of metabolic landscape were detected by MALDI-MSI. The underlying mechanisms of autophagy reducing by AKBA treatment were determined by immunoblotting and immunofluorescence, respectively. Transmission electron microscope was used to check morphology of cells treated by AKBA. Our results showed that AKBA (100 mg/kg) significantly inhibited the growth of orthotopic U87-MG gliomas. Results from MALDI-MSI showed that AKBA improved the metabolic profile of mice with glioblastoma, while immunoblot assays revealed that AKBA suppressed the expression of ATG5, p62, LC3B, p-ERK/ERK, and P53, and increased the ratio of p-mTOR/mTOR. Taken together, these results suggested that the antitumor effects of AKBA were related to the normalization of aberrant metabolism in the glioblastoma and the inhibition of autophagy. AKBA could be a promising chemotherapy drug for glioblastoma.
		                        		
		                        		
		                        		
		                        	
5.Investigation and analysis of specialty categories in independent medical universities in Liaoning Province
Xiangjin KONG ; Weiwei LIU ; Jing XIAO
Chinese Journal of Medical Education Research 2018;17(3):316-320
		                        		
		                        			
		                        			Using specialty and university as two statistical units,the author analyzes specialty categories,specialty composition,and the number of the disciplines established by seven independent medical universities,and indicates that in those surveyed medical universities,there is a sweeping trend of specialty diversity and generalization of non-medical specialties that most of them however have no relation with medical science and pharmacy.The author also displays negative effects of the generalization of non-medical specialties,especially on the development of medical universities,and comes up with some corresponding strategies to improve specialty setup.
		                        		
		                        		
		                        		
		                        	
6.Ganglioside GD3 synthase (GD3S), a novel cancer drug target.
Jinyi LIU ; Xiangjin ZHENG ; Xiaocong PANG ; Li LI ; Jinhua WANG ; Cui YANG ; Guanhua DU
Acta Pharmaceutica Sinica B 2018;8(5):713-720
		                        		
		                        			
		                        			Gangliosides are a class of important glycosphingolipids containing sialic acid that are widely distributed on the outer surface of cells and are abundantly distributed in brain tissue. Disialoganglioside with three glycosyl groups (GD3) and disialoganglioside with two glycosyl groups (GD2) are markedly increased in pathological conditions such as cancers and neurodegenerative diseases. GD3 and GD2 were found to play important roles in cancers by mediating cell proliferation, migration, invasion, adhesion, angiogenesis and in preventing immunosuppression of tumors. GD3 synthase (GD3S) is the regulatory enzyme of GD3 and GD2 synthesis, and is important in tumorigenesis and the development of cancers. The study of GD3S as a drug target may be of great significance for the discovery of new drugs for cancer treatment. This review will describe the gangliosides and their roles in physiological and pathological conditions; the roles of GD3 and GD2 in cancers; the expression, functions and mechanisms of GD3S, and its potential as a drug target in cancers.
		                        		
		                        		
		                        		
		                        	
7.Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
Yi YANG ; Han WU ; Xiangjin KANG ; Yanhui LIANG ; Ting LAN ; Tianjie LI ; Tao TAN ; Jiangyun PENG ; Quanjun ZHANG ; Geng AN ; Yali LIU ; Qian YU ; Zhenglai MA ; Ying LIAN ; Boon Seng SOH ; Qingfeng CHEN ; Ping LIU ; Yaoyong CHEN ; Xiaofang SUN ; Rong LI ; Xiumei ZHEN ; Ping LIU ; Yang YU ; Xiaoping LI ; Yong FAN
Protein & Cell 2018;9(3):283-297
		                        		
		                        			
		                        			Mitochondrial diseases are maternally inherited heterogeneous disorders that are primarily caused by mitochondrial DNA (mtDNA) mutations. Depending on the ratio of mutant to wild-type mtDNA, known as heteroplasmy, mitochondrial defects can result in a wide spectrum of clinical manifestations. Mitochondria-targeted endonucleases provide an alternative avenue for treating mitochondrial disorders via targeted destruction of the mutant mtDNA and induction of heteroplasmic shifting. Here, we generated mitochondrial disease patient-specific induced pluripotent stem cells (MiPSCs) that harbored a high proportion of m.3243A>G mtDNA mutations and caused mitochondrial encephalomyopathy and stroke-like episodes (MELAS). We engineered mitochondrial-targeted transcription activator-like effector nucleases (mitoTALENs) and successfully eliminated the m.3243A>G mutation in MiPSCs. Off-target mutagenesis was not detected in the targeted MiPSC clones. Utilizing a dual fluorescence iPSC reporter cell line expressing a 3243G mutant mtDNA sequence in the nuclear genome, mitoTALENs displayed a significantly limited ability to target the nuclear genome compared with nuclear-localized TALENs. Moreover, genetically rescued MiPSCs displayed normal mitochondrial respiration and energy production. Moreover, neuronal progenitor cells differentiated from the rescued MiPSCs also demonstrated normal metabolic profiles. Furthermore, we successfully achieved reduction in the human m.3243A>G mtDNA mutation in porcine oocytes via injection of mitoTALEN mRNA. Our study shows the great potential for using mitoTALENs for specific targeting of mutant mtDNA both in iPSCs and mammalian oocytes, which not only provides a new avenue for studying mitochondrial biology and disease but also suggests a potential therapeutic approach for the treatment of mitochondrial disease, as well as the prevention of germline transmission of mutant mtDNA.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			DNA, Mitochondrial
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Induced Pluripotent Stem Cells
		                        			;
		                        		
		                        			cytology
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			MELAS Syndrome
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Microsatellite Repeats
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Mitochondria
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			genetics
		                        			
		                        		
		                        	
8.The efficacy and safety of insulin degludec versus insulin glargine in insulin-naive subjects with type 2 diabetes: results of a Chinese cohort from a multinational randomized controlled trial
Yiming MU ; Lixin GUO ; Ling LI ; Yiming LI ; Xiangjin XU ; Quanmin LI ; Mingtong XU ; Lyuyun ZHU ; Guoyue YUAN ; Yu LIU ; Chun XU ; Zhanjian WANG ; Feixia SHEN ; Yong LUO ; Jianying LIU ; Qifu LI ; Wenhui WANG ; Xiaoyang LAI ; Hongfei XU ; Changyu PAN
Chinese Journal of Internal Medicine 2017;56(9):660-666
		                        		
		                        			
		                        			Objective To compare the safety and efficacy of insulin degludec (IDeg) with those of insulin glargine (IGlar) in insulin-naive subjects with type 2 diabetes (T2DM).Methods This was a 26-week,randomized,open-label,parallel-group,treat-to-target trial in 560 Chinese subjects with T2DM (men/women:274/263,mean age 56 years,mean diabetes duration 7 years) inadequately controlled on oral antidiabetic drugs (OADs).Subjects were randomized 2:1 to once-daily IDeg (373 subjects) or IGlar(187 subjects),both in combination with metformin.The primary endpoint was changes from baseline in glycosylated hemoglobin(HbA1c) after 26 weeks.Results Mean HbA1c decreased from 8.2% in both groups to 6.9% in IDeg and 7.0% in IGlar,respectively.Estimated treatment difference (ETD) of IDegIGlar in change from baseline was-0.10% points (95% CI-0.25-0.05).The proportion of subjects achieving HbA1c < 7.0% was 56.3% and 49.7% with IDeg and IGlar,respectively [estimated odds ratio of IDeg/IGlar:1.26 (95 % CI 0.88-1.82)].Numerically lower rateof overall confirmed hypoglycaemia and statistically significantly lower nocturnal confirmed hypoglycemia were associated with IDeg compared with IGlar,respectively [estimated rateratio of IDeg/IGlar 0.69 (95% CI 0.46-1.03),and 0.43 (95% CI 0.19-0.97)].No differences in other safety parameters were found between the two groups.Conclusions IDeg was non-inferior to IGlar in terms of glycaemic control,and was associated with a statistically significantly lower rate of nocturnal confirmed hypoglycaemia.IDeg is considered to be suitable for initiating insulin therapy in Chinese T2DM patients on OADs requiring intensified treatment.Clinical trail registration Clinicaltrials.gov,NCT01849289.
		                        		
		                        		
		                        		
		                        	
10.Generation of pluripotent stem cells using non-integrated approach in human azoospermia patients
Hansheng YANG ; Qian YU ; Yali LIU ; Yong FAN ; Xiangjin KANG
Tianjin Medical Journal 2017;45(5):前插1,454-457
		                        		
		                        			
		                        			Objective To establish induced pluripotent stem cells (iPSCs) in patients with azoospermia by non-integrated approach. Methods Using the commercially available serum-free medium (TeSR?2) and embryonic stem cell culture medium (Stem Adhere? Defined Matrix) to define the culture system, the iPSCs were established by using non-integrated Sendai virus infection in peripheral blood mononuclear cells of azoospermia patients. The immunofluorescence, karyotype analysis, embryoid body differentiation and teratoma formation were used to identify pluripotency, karyotype and differentiation ability of iPSCs. Results The established iPSCs showed the characteristics of human embryonic stem cells. Immunofluorescence analysis showed that octamer-binding transcription factor 4 (OCT4), SRY-related-box protein-2 (SOX2), stage-specific embryonic antigen-4 (SSEA-4) and tumor rejection antigen-1-60 (TRA-1-60) were positive for the expression of stem cell pluripotency markers. Karyotype analysis showed that they had normal karyotype. In addition, embryoid body and teratoma tests showed that the iPSCs had the ability to differentiate into three germ layers in vitro and in vivo. Conclusion The induction of pluripotent stem cell line is successfully constructed by non-integrated approach in azoospermia patients.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail